Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy

Author： Hasumi Kenichiro   Aoki Yukimasa   Watanabe Ryuko   Hankey Kim G.   Mann Dean L.  

Publisher： MDPI

E-ISSN： 2072-6694|3|2|2223-2242

ISSN： 2072-6694

Source： Cancers, Vol.3, Iss.2, 2011-04, pp. : 2223-2242

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation

By Sittig Simone P.   de Vries I. Jolanda M.   Schreibelt Gerty  

Biomedicines, Vol. 3, Iss. 4, 2015-12 ,pp. : 282-303

MDPI

Access to resources Recommend Favorite

γδ T Cell Immunotherapy—A Review

By Kobayashi Hirohito   Tanaka Yoshimasa  

Pharmaceuticals, Vol. 8, Iss. 1, 2015-02 ,pp. : 40-61

MDPI

Access to resources Recommend Favorite

Analysis of Intensity-Modulated Radiation Therapy (IMRT), Proton and 3D Conformal Radiotherapy (3D-CRT) for Reducing Perioperative Cardiopulmonary Complications in Esophageal Cancer Patients

By Ling Ted C.   Slater Jerry M.   Nookala Prashanth   Mifflin Rachel   Grove Roger   Ly Anh M.   Patyal Baldev   Slater Jerry D.   Yang Gary Y.  

Cancers, Vol. 6, Iss. 4, 2014-12 ,pp. : 2356-2368

MDPI

Access to resources Recommend Favorite

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

By Koido Shigeo  

International Journal of Molecular Sciences, Vol. 17, Iss. 6, 2016-05 ,pp. : 828-828

MDPI

Access to resources Recommend Favorite

Dendritic Cell Regulation by Cannabinoid-Based Drugs

By Svensson Mattias   Chen Puran   Hammarfjord Oscar  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-08 ,pp. : 2733-2750

MDPI

Access to resources Recommend Favorite